Stay updated on Ampion Therapy in Adult COVID-19 Patients Clinical Trial

Sign up to get notified when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The record for the Phase 1 Ampion COVID-19 study is displayed with its trial design, outcome measures, eligibility criteria, recruitment status, and study dates.
    Difference
    43%
    Check dated 2026-11-09T13:22:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T13:18:16.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A banner announces updates to NIH websites and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:32:35.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:16:21.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:50.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page displays a 403 Forbidden error, replacing the usual study details with an access-denied message. The changes insert the 403 content and remove many study-related sections, resulting in an inaccessible study entry.
    Difference
    17%
    Check dated 2026-09-21T22:18:05.000Z thumbnail image

Stay in the know with updates to Ampion Therapy in Adult COVID-19 Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ampion Therapy in Adult COVID-19 Patients Clinical Trial page.